It is a recombinant monoclonal antibody with human structural regions and the binding regions of a murine antibody to the active isoforms of VEGF, mainly the VEGF-A isoform, inhibiting angiogenesis and preventing tumor growth and proliferation. Here, VEGFA is linked to neoplasm.